Development of serum IgM antibodies against superantigens ofStaphylococcus aureusandStreptococcus pyogenesin Kawasaki disease
Authors:
Open Access
- 16 February 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 143 (3) , 427-434
Abstract
To serologically determine the association of microbial superantigens and the pathogenesis of Kawasaki disease (KD), we conducted a case‐control study. Serum IgG and IgM antibodies against staphylococcal enterotoxin A (SEA), SEB, SEC, toxic shock syndrome toxin‐1 (TSST‐1), and streptococcal pyrogenic exotoxin A (SPEA) were measured by an enzyme‐linked immunosorbent assay in 293 serum samples from 65 KD patients on clinical days 1–28 and 120 control samples. The administration of immunoglobulin products, which contain high concentrations of IgG antibodies against all the superantigens, directly elevated antitoxin IgG antibodies in KD patients. In contrast, antitoxin IgM antibodies were not detected in immunoglobulin products. Actually, we found a significant elevation of IgM antibodies against SEA in KD patients in the first (median titre: 0·020, P < 0·01 versus control), second (0·024, P < 0·001), third (0·030, P < 0·001) and fourth (0·038, P < 0·001) weeks, compared to the controls (0·015). Significant differences of IgM antibodies were also true for SEB, TSST‐1, and SPEA throughout the first to fourth weeks, and for SEC throughout the second to fourth weeks. The prevalence of KD patients having high IgM titres (> mean + 2SD of control values) to the 5 superantigens was increased with the clinical weeks, and reached 29–43% of KD subjects at the fourth week. This is the first study that describes kinetics of IgM antibodies against superantigens and clarifies the serological significance throughout the clinical course of KD. Our results suggest that multiple superantigens involve in the pathogenesis of KD.Keywords
This publication has 28 references indexed in Scilit:
- Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of ageThe Pediatric Infectious Disease Journal, 2003
- Maternal Antibody against Toxic Shock Syndrome Toxin–1 May Protect Infants Younger than 6 Months of Age from Developing Kawasaki SyndromeThe Journal of Infectious Diseases, 2002
- Human Antibodies to Bacterial Superantigens and Their Ability To Inhibit T-Cell Activation and LethalityAntimicrobial Agents and Chemotherapy, 2001
- Polyclonal expansion of TCRBV2‐ and TCRBV6‐bearing T cells in patients with Kawasaki diseaseImmunology, 1999
- T Cell‐Dependent Antibody Response to Staphylococcal Enterotoxin BScandinavian Journal of Immunology, 1995
- The Absence of Evidence of Staphylococcal Toxin Involvement in the Pathogenesis of Kawasaki DiseaseThe Journal of Infectious Diseases, 1995
- Evidence for a superantigen mediated process in Kawasaki disease.Archives of Disease in Childhood, 1995
- Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]Journal of Clinical Investigation, 1993
- Immunoregulatory abnormalities in mucocutaneous lymph node syndromeClinical Immunology and Immunopathology, 1982
- Dysfunctions of Pokeweed Mitogen-stimulated T and B Lymphocyte Responses Induced by Gammaglobulin TherapyJournal of Clinical Investigation, 1981